Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$84.3 - $94.31 $23,266 - $26,029
-276 Reduced 0.8%
34,379 $3.14 Billion
Q1 2024

Apr 17, 2024

SELL
$72.54 - $95.56 $135,939 - $179,079
-1,874 Reduced 5.13%
34,655 $3.27 Billion
Q4 2023

Jan 17, 2024

SELL
$61.71 - $77.76 $107,498 - $135,457
-1,742 Reduced 4.55%
36,529 $2.79 Billion
Q3 2023

Oct 18, 2023

SELL
$69.28 - $93.38 $75,723 - $102,064
-1,093 Reduced 2.78%
38,271 $2.65 Billion
Q2 2023

Jul 18, 2023

BUY
$81.41 - $94.33 $345,422 - $400,242
4,243 Added 12.08%
39,364 $3.71 Billion
Q1 2023

Apr 18, 2023

BUY
$74.26 - $84.51 $7,648 - $8,704
103 Added 0.29%
35,121 $2.91 Billion
Q4 2022

Jan 19, 2023

BUY
$68.3 - $87.44 $2.39 Million - $3.06 Million
35,018 New
35,018 $2.61 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fiduciary Alliance LLC Portfolio

Follow Fiduciary Alliance LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Alliance LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Alliance LLC with notifications on news.